Novo Holdings A/S Q1 2016 Filing
Filed May 16, 2016
Portfolio Value
$912.5B
Holdings
17
Report Date
Q1 2016
Filing Type
13F-HR
All Holdings (17 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | VTIVANGUARD INDEX FDS | 2,837,100 | $297.4B | 32.59% | |
| 2 | —OPHTHOTECH CORP | 4,910,487 | $207.6B | 22.75% | |
| 3 | INGNINOGEN INC | 3,549,320 | $159.6B | 17.50% | |
| 4 | VGKVANGUARD INTL EQUITY INDEX F | 2,101,000 | $101.9B | 11.17% | |
| 5 | CRVSCORVUS PHARMACEUTICALS INC | 3,154,046 | $45.7B | 5.01% | |
| 6 | —COLUCID PHARMACEUTICALS INC | 3,056,563 | $19.0B | 2.08% | |
| 7 | —TOBIRA THERAPEUTICS INC | 2,281,405 | $18.7B | 2.05% | |
| 8 | XLRNACCELERON PHARMA INC | 673,063 | $17.8B | 1.95% | |
| 9 | PENPENUMBRA, INC. | 263,191 | $12.1B | 1.33% | |
| 10 | —NABRIVA THERAPEUTICS AG | 874,985 | $7.8B | 0.86% | |
| 11 | —INVUITY INC | 936,193 | $6.8B | 0.74% | |
| 12 | —WRIGHT MED GROUP N V | 4,622,032 | $5.8B | 0.63% | |
| 13 | —HTG MOLECULAR DIAGNOSTICS INC | 1,280,185 | $3.7B | 0.40% | |
| 14 | —SPECTRANETICS CORP | 236,826 | $3.4B | 0.38% | |
| 15 | —TOKAI PHARMACEUTICALS INC | 470,946 | $2.6B | 0.29% | |
| 16 | GKOSGLAUKOS CORP | 101,106 | $1.7B | 0.19% | |
| 17 | XENEXENON PHARMACEUTICALS INC | 127,563 | $892.0M | 0.10% |